GENMAB AS SP.ADR/1/10DK 1 Free Cash Flow Generation Index
GENMAB AS SP.ADR/1/10DK 1 free cash flow generation index. GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of €288.00 Million represents 1% of operating cash flow (€301.00 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
Free cash flow generation index of GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025. Historical FCF Generation Index trend for GENMAB AS SP.ADR/1/10DK 1 across 5 annual periods. See GE91 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
GENMAB AS SP.ADR/1/10DK 1 Free Cash Flow Generation Index by Year (2021–2025)
GENMAB AS SP.ADR/1/10DK 1 free cash flow generation index by year from 2021 to 2025. Year-by-year Free Cash Flow Generation Index for GENMAB AS SP.ADR/1/10DK 1. For the full cash flow conversion analysis, see GE91 cash flow metrics.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.95x | €1.13 Billion | €1.19 Billion | €55.00 Million | ▼ -0.8% |
| 2024 | 0.96x | €1.04 Billion | €1.08 Billion | €42.41 Million | ▲ +1.2% |
| 2023 | 0.95x | €1.04 Billion | €1.10 Billion | €55.83 Million | ▲ +3.3% |
| 2022 | 0.92x | €517.42 Million | €563.05 Million | €45.63 Million | ▲ +3.6% |
| 2021 | 0.89x | €300.82 Million | €339.18 Million | €38.36 Million | — |